Trial record 1 of 1 for:    NCT00832208
Previous Study | Return to List | Next Study

Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With Visceral Leishmaniasis

This study has been terminated.
Sponsor:
Collaborator:
Addis Ababa University
Information provided by:
Drugs for Neglected Diseases
ClinicalTrials.gov Identifier:
NCT00832208
First received: January 29, 2009
Last updated: March 9, 2011
Last verified: March 2011